|
CONCOMITANT USE SHOULD BE AVOIDED
|
SYMPATHOMIMETICS ARRHYTHMOGENIC EFFECT IS POTENTIATED BY THE DRUG
|
SYMPATHOMIMETICS ARRHYTHMOGENIC EFFECT IS POTENTIATED BY THE DRUG
|
INCREASED CHANCES OF PERIPHERAL NEUROPATHY
|
CO-ADMINISTRATION MAY POTENTIATE HYPERTENSIVE EFFECT OF THE DRUG
|
FRUSEMIDE MAY ADD TO OR POTENTIATE THE THERAPEUTIC OF OTHER ANTIHYPERTENSIVE DRUGS
|
FRUSEMIDE MAY ADD TO OR POTENTIATE THE THERAPEUTIC OF OTHER ANTIHYPERTENSIVE DRUGS
|
FRUSEMIDE MAY ADD TO OR POTENTIATE THE THERAPEUTIC OF OTHER ANTIHYPERTENSIVE DRUGS
|
FRUSEMIDE MAY ADD TO OR POTENTIATE THE THERAPEUTIC OF OTHER ANTIHYPERTENSIVE DRUGS
|
AMPHETAMINE MAY REDUCE THE HYPOTENSIVE EFFECTS OF ANTIHYPERTENSIVES INCLUDING BETABLOCKERS
|
AMPHETAMINE MAY REDUCE THE HYPOTENSIVE EFFECTS OF ANTIHYPERTENSIVES INCLUDING BETABLOCKERS
|
AMPHETAMINE MAY REDUCE THE HYPOTENSIVE EFFECTS OF ANTIHYPERTENSIVES INCLUDING BETABLOCKERS
|
AMPHETAMINE MAY REDUCE THE HYPOTENSIVE EFFECTS OF ANTIHYPERTENSIVES INCLUDING BETABLOCKERS
|
INCREASED HYPOTENSIVE EFFECT IS SEEN
|
INCREASED HYPOTENSIVE EFFECT IS SEEN
|
INCREASED HYPOTENSIVE EFFECT IS SEEN
|
INCREASED HYPOTENSIVE EFFECT IS SEEN
|
INCREASED HYPOTENSIVE EFFECT IS SEEN
|
INCREASED HYPOTENSIVE EFFECT IS SEEN
|
INCREASED HYPOTENSIVE EFFECT IS SEEN
|
INCREASED HYPOTENSIVE EFFECT IS SEEN
|
INCREASED HYPOTENSIVE EFFECT IS SEEN
|
INCREASED HYPOTENSIVE EFFECT IS SEEN
|
INCREASED HYPOTENSIVE EFFECT IS SEEN
|
INCREASED HYPOTENSIVE EFFECT IS SEEN
|
INCREASED HYPOTENSIVE EFFECT IS SEEN
|
INCREASED HYPOTENSIVE EFFECT IS SEEN
|
CO-ADMINISTRATION WITH OTHER ANTIHYPERTENSIVES MAY RESULT IN ADDITIVE EFFECT OR POTENTIATION
|
CO-ADMINISTRATION WITH OTHER ANTIHYPERTENSIVES MAY RESULT IN ADDITIVE EFFECT OR POTENTIATION
|
CO-ADMINISTRATION WITH OTHER ANTIHYPERTENSIVES MAY RESULT IN ADDITIVE EFFECT OR POTENTIATION
|
CO-ADMINISTRATION WITH OTHER ANTIHYPERTENSIVES MAY RESULT IN ADDITIVE EFFECT OR POTENTIATION
|
CO-ADMINISTRATION WITH OTHER ANTIHYPERTENSIVES MAY RESULT IN ADDITIVE EFFECT OR POTENTIATION
|
CO-ADMINISTRATION WITH OTHER ANTIHYPERTENSIVES MAY RESULT IN ADDITIVE EFFECT OR POTENTIATION
|
CO-ADMINISTRATION WITH OTHER ANTIHYPERTENSIVES MAY RESULT IN ADDITIVE EFFECT OR POTENTIATION
|
CO-ADMINISTRATION WITH OTHER ANTIHYPERTENSIVES MAY RESULT IN ADDITIVE EFFECT OR POTENTIATION
|
CO-ADMINISTRATION WITH OTHER ANTIHYPERTENSIVES MAY RESULT IN ADDITIVE EFFECT OR POTENTIATION
|
CO-ADMINISTRATION WITH OTHER ANTIHYPERTENSIVES MAY RESULT IN ADDITIVE EFFECT OR POTENTIATION
|
CO-ADMINISTRATION WITH OTHER ANTIHYPERTENSIVES MAY RESULT IN ADDITIVE EFFECT OR POTENTIATION
|
CO-ADMINISTRATION WITH OTHER ANTIHYPERTENSIVES MAY RESULT IN ADDITIVE EFFECT OR POTENTIATION
|
MAOIS CAN CAUSE SEVERE HYPOTENSION WHEN GIVEN CONCURRENTLY
|
MAOIS CAN CAUSE SEVERE HYPOTENSION WHEN GIVEN CONCURRENTLY
|
MAOIS CAN CAUSE SEVERE HYPOTENSION WHEN GIVEN CONCURRENTLY
|
MAOIS CAN CAUSE SEVERE HYPOTENSION WHEN GIVEN CONCURRENTLY
|
MAOIS CAN CAUSE SEVERE HYPOTENSION WHEN GIVEN CONCURRENTLY
|
MAOIS CAN CAUSE SEVERE HYPOTENSION WHEN GIVEN CONCURRENTLY
|